We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
01 4Alfred E Tiefenbacher GmbH
02 3Breckenridge Pharmaceutical
03 4Douglas CDMO
04 4Pharmathen SA
05 42care4
06 5A Pharma Gmbh
07 8Actavis Inc
08 12Almirall
09 3Alvogen
10 3Amneal Pharmaceuticals
11 3Apotex Fermentation Inc.
12 3Aristo Pharma GmbH
13 3Ascent Innovative Medicines
14 12Aurobindo Pharma Limited
15 3Aurovitas Spain, Sau
16 5Biofarma Pharmaceutical Industry and Commerce Inc
17 3Cinfa
18 3DOC Generici
19 5Esteve Quimica
20 5Hexal AG
21 2Jeil Pharmaceutical Co., Ltd
22 3Kern Pharma S.L.
23 3Knight Therapeutics
24 16Krka
25 4LABORATORIOS NORMON SA
26 4Macleods Pharmaceuticals Limited
27 2Myungmoon Pharm. Co., LTD.
28 10Neuraxpharm
29 75Novartis Pharmaceuticals Corporation
30 4Novartis South Africa (Pty) Ltd
31 1ORIFARM GROUP AS
32 4Orchid Pharma
33 3Ratiopharm Espana Sa
34 11STADA Arzneimittel
35 2Samyang Biopharmaceuticals
36 27Sandoz B2B
37 2Tecnimede
38 13Teva Pharmaceutical Industries
39 8Torrent Pharmaceuticals Limited
40 13Viatris
41 4Vir Sa Chemical And Pharmaceutical Industry
42 5World Medicine
43 3Yichang Humanwell Pharmaceutical
44 7Zentiva
45 3Zydus Pharmaceuticals
01 8CAP
02 16CAPSULE
03 53Capsule
04 3ER Film
05 21FILM, EXTENDED RELEASE;TRANSDERMAL
06 3H Transdermal Patch
07 2H Transdermal Patches
08 40Hard Capsule
09 8Hard Capsule Oral
10 8Hard Capsules
11 1ORAL SOLUTION
12 9Oral Solution
13 8Orodispersible Tablet
14 11PATCH
15 2Patch
16 1Patches
17 5Rivastigmine 1,5Mg 56 Combined Oral Use
18 5Rivastigmine 3Mg 56 Combined Oral Use
19 5Rivastigmine 4,5Mg 56 Combined Oral Use
20 3Rivastigmine 4,6Mg/Die 30 Plasters Transdermal Use
21 5Rivastigmine 6Mg 56 Combined Oral Use
22 3Rivastigmine 9,5Mg/Die 30 Plasters Transdermal Use
23 1Solution
24 1Syrup
25 86Transdermal Patch
26 2Transdermal Patches
27 14Blank
01 77Authorized
02 21Cancelled
03 3DISCN
04 4EU Approved
05 10Generic
06 4Generic Approved DCP
07 2Generic B.E study
08 4Generic EU CTD
09 11Marketed
10 7Not Marketed
11 4Originator
12 50Prescription
13 18RX
14 4Registered in EU
15 3Suspended
16 102Blank
01 3Alzerta
02 2Alzerta Dos Por Semana
03 22Astigmina
04 3DEMELORA
05 2DEMENCURE
06 13EXELON
07 1EXELON PATCH 10
08 1EXELON PATCH 15
09 1EXELON PATCH 5
10 53Exelon
11 1Exelon 1.5 mg
12 1Exelon 6 mg
13 2Exelon Patch 10
14 2Exelon Patch 15
15 2Exelon Patch 5
16 1Kyriz 1,5 MG
17 1Kyriz 3 MG
18 1Kyriz 4,5 MG
19 1Kyriz 6 MG
20 1MYLAN-RIVASTIGMINE PATCH 10
21 1MYLAN-RIVASTIGMINE PATCH 5
22 4NIMVASTID
23 8Nimvastid
24 4Nvastid
25 25Prometax
26 4RIVASTIGMINA AUROBINDO
27 3RIVASTIGMINA DOC
28 4RIVASTIGMINA MYLAN PHARMA
29 5RIVASTIGMINA SANDOZ
30 2RIVASTIGMINA SANDOZ GMBH
31 1RIVASTIGMINA SANDOZ GmbH
32 18RIVASTIGMINE
33 3RIVASTIGMINE ZENTIVA
34 5RIVASTORON
35 5Ristart
36 3Rivanex
37 4Rivanex Flas
38 2Rivaron
39 3Rivastigmin Tevagen
40 3Rivastigmina Aristo
41 3Rivastigmina Aurovitas Spain
42 3Rivastigmina Cinfa
43 3Rivastigmina Kern Pharma
44 3Rivastigmina Ratio
45 3Rivastigmina Sandoz
46 3Rivastigmina Stadafarma
47 2Rivastigmina Tecnigen
48 3Rivastigmina Teva
49 2Rivastigmina Viatris
50 4Rivastigmina Vir
51 5Rivastigmine 1 A Pharma
52 4Rivastigmine Actavis
53 3Rivastigmine Apotex
54 5Rivastigmine Hexal
55 4Rivastigmine Normon
56 3Rivastigmine Ratiopharm
57 5Rivastigmine Sandoz
58 8Rivastigmine Stada
59 2Rivastigmine Zentiva
60 1SANDOZ RIVASTIGMINE PATCH 10
61 1SANDOZ RIVASTIGMINE PATCH 5
62 33Blank
01 14Australia
02 7Canada
03 43Estonia
04 4Germany
05 4Greece
06 15India
07 65Italy
08 4New Zealand
09 18Norway
10 8South Africa
11 6South Korea
12 101Spain
13 10Turkey
14 21USA
15 4United Kingdom
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 1.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : RX
Registration Country : USA
Brand Name : RIVASTIGMINE
Dosage Form : FILM, EXTENDED RELEASE;TRANSDERMAL
Dosage Strength : 4.6MG/24HR
Packaging :
Approval Date : 2019-11-26
Application Number : 209063
Regulatory Info : RX
Registration Country : USA
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Regulatory Info : Generic
Registration Country : New Zealand
Brand Name :
Dosage Form : CAPSULE
Dosage Strength : 1.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : New Zealand
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 1.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 1.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : RX
Registration Country : USA
Brand Name : RIVASTIGMINE
Dosage Form : FILM, EXTENDED RELEASE;TRANSDERMAL
Dosage Strength : 9.5MG/24HR
Packaging :
Approval Date : 2019-11-26
Application Number : 209063
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RIVASTIGMINE
Dosage Form : FILM, EXTENDED RELEASE;TRANSDERMAL
Dosage Strength : 13.3MG/24HR
Packaging :
Approval Date : 2019-11-26
Application Number : 209063
Regulatory Info : RX
Registration Country : USA
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Regulatory Info : Generic
Registration Country : New Zealand
Brand Name :
Dosage Form : CAPSULE
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : New Zealand
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Regulatory Info : Generic
Registration Country : New Zealand
Brand Name :
Dosage Form : CAPSULE
Dosage Strength : 4.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : New Zealand
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Regulatory Info : Generic
Registration Country : New Zealand
Brand Name :
Dosage Form : CAPSULE
Dosage Strength : 6MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : New Zealand
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 4.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 6MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : RX
Registration Country : USA
Brand Name : EXELON
Dosage Form : FILM, EXTENDED RELEASE;TRANSDERMAL
Dosage Strength : 4.6MG/24HR
Packaging :
Approval Date : 2007-07-06
Application Number : 22083
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EXELON
Dosage Form : FILM, EXTENDED RELEASE;TRANSDERMAL
Dosage Strength : 9.5MG/24HR
Packaging :
Approval Date : 2007-07-06
Application Number : 22083
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Cancelled
Registration Country : Spain
Brand Name : Rivastigmine Stada
Dosage Form : Oral Solution
Dosage Strength : 2MG
Packaging :
Approval Date : 08-03-2010
Application Number : 71945
Regulatory Info : Cancelled
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Rivastigmin Tevagen
Dosage Form : Transdermal Patch
Dosage Strength : 13.3MG
Packaging :
Approval Date : 05-04-2022
Application Number : 86432
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Rivastigmina Vir
Dosage Form : Hard Capsule
Dosage Strength : 6MG
Packaging :
Approval Date : 08-11-2013
Application Number : 76270
Regulatory Info : Authorized
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
